Collegium Pharmaceutical, Inc. (COLL)
USD 30.02
(-2.85%)
USD 30.02
(-2.85%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 274.74 Million | 124.23 Million | 103.55 Million | 93.94 Million | 27.78 Million | 169.39 Million |
| Net Income | 48.15 Million | -25 Million | 71.51 Million | 26.75 Million | -22.72 Million | -39.12 Million |
| Depreciation & Amortization | 149.25 Million | 138.93 Million | 68.91 Million | 61.55 Million | 15.48 Million | 110.9 Million |
| Deferred income taxes | -2.15 Million | -8.39 Million | -78.04 Million | - | - | - |
| Stock-based compensation | 27.13 Million | 22.87 Million | 24.25 Million | 21.91 Million | 16.52 Million | 13.77 Million |
| Change in working capital | 21.73 Million | -12.71 Million | 13.48 Million | -25.29 Million | 18.18 Million | 64.55 Million |
| Other non-cash items | 30.62 Million | 8.52 Million | 3.42 Million | 9.02 Million | 313 Thousand | 19.28 Million |
| Investing Cash Flow | -70.81 Million | -573.69 Million | -1.94 Million | -373.77 Million | -6.43 Million | -24.35 Million |
| Investments in PPE | -461 Thousand | -1.62 Million | -1.94 Million | -373.77 Million | -6.43 Million | -24.35 Million |
| Acquisitions | - | -572.06 Million | - | - | - | - |
| Investment purchases | -92.35 Million | - | - | - | - | - |
| Sales/Maturities of investments | 22 Million | - | - | - | - | - |
| Other Investing Activities | -70.35 Million | - | - | -368.22 Million | - | -18.87 Million |
| Financing Cash Flow | -140.17 Million | 436.72 Million | -89.3 Million | 286.47 Million | 2.04 Million | -117.19 Million |
| Debt repayment | -59.63 Million | -75 Million | -50 Million | -289.32 Million | - | -10.02 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -83.36 Million | -14.06 Million | -52.01 Million | -2.25 Million | -822 Thousand | -30 Thousand |
| Common Stock Issuance | 9.1 Million | 11.81 Million | 12.7 Million | 7.33 Million | 2.86 Million | -30 Thousand |
| Other Financing Activities | 2.82 Million | 513.97 Million | 12.7 Million | -594 Thousand | 2.86 Million | -117.13 Million |
| Accounts receivables | 3.59 Million | -21.78 Million | -22.52 Million | -10.36 Million | 4.99 Million | -68.23 Million |
| Accounts payables | 5.06 Million | -707 Thousand | -5.82 Million | 3.76 Million | -5.9 Million | 6.46 Million |
| Inventory | 14.16 Million | 48.27 Million | -2.29 Million | -8.27 Million | -1.82 Million | 219 Thousand |
| Other working capital | -1.09 Million | -38.5 Million | 44.13 Million | -10.43 Million | 20.91 Million | 126.09 Million |
| Cash at beginning of period | 176.23 Million | 188.97 Million | 176.66 Million | 170.01 Million | 146.63 Million | 118.79 Million |
| Cash at end of period | 239.99 Million | 176.23 Million | 188.97 Million | 176.66 Million | 170.01 Million | 146.63 Million |
| Capital Expenditure | -461 Thousand | -1.62 Million | -1.94 Million | -373.77 Million | -6.43 Million | -24.35 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 63.75 Million | -12.73 Million | 12.31 Million | 6.64 Million | 23.38 Million | 27.83 Million |
| Free Cash Flow | 274.28 Million | 122.6 Million | 101.61 Million | -279.83 Million | 21.34 Million | 145.03 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 19.6 Million | 27.71 Million | 31.94 Million | 48.15 Million | 20.63 Million | 13 Million |
| Depreciation & Amortization | 35.46 Million | 35.43 Million | 35.46 Million | 149.25 Million | 37.15 Million | 38.35 Million |
| Deferred income taxes | -3.51 Million | -4.41 Million | -338 Thousand | -2.15 Million | -1.13 Million | -636 Thousand |
| Stock-based compensation | 10.01 Million | 7.47 Million | 7 Million | 27.13 Million | 7.02 Million | 7.07 Million |
| Change in working capital | -2.21 Million | -5.61 Million | -2.1 Million | 21.73 Million | 8.82 Million | 39.86 Million |
| Other non-cash items | 98.34 Million | 76.33 Million | 1.37 Million | 30.62 Million | 1.51 Million | 2.05 Million |
| Investing Cash Flow | -8.9 Million | -18.12 Million | -25.09 Million | -70.81 Million | -3.82 Million | -41.71 Million |
| Investments in PPE | -270 Thousand | -568 Thousand | -164 Thousand | -461 Thousand | -65 Thousand | -56 Thousand |
| Acquisitions | - | - | -35.66 Million | - | -6 Million | - |
| Investment purchases | -34.29 Million | -39.11 Million | -40.93 Million | -92.35 Million | -9.75 Million | -41.66 Million |
| Sales/Maturities of investments | 25.65 Million | 21.55 Million | 16 Million | 22 Million | 6 Million | - |
| Other Investing Activities | - | -17.56 Million | 35.66 Million | -70.35 Million | 6 Million | -41.66 Million |
| Financing Cash Flow | -114.2 Million | -54.14 Million | -67.82 Million | -140.17 Million | -95.41 Million | -45.23 Million |
| Debt repayment | -45.83 Million | -45.83 Million | -39.55 Million | -59.63 Million | -45.83 Million | -46.26 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -35 Million | -12.87 Million | -25.23 Million | -83.36 Million | -50.17 Million | -220 Thousand |
| Common Stock Issuance | 5.71 Million | 4.56 Million | 3.24 Million | 9.1 Million | 593 Thousand | 1.25 Million |
| Other Financing Activities | -39.09 Million | -12.87 Million | -3.04 Million | 2.82 Million | 593 Thousand | 1.25 Million |
| Accounts receivables | -9.16 Million | 4.83 Million | 2.32 Million | 3.59 Million | -14.37 Million | 11.64 Million |
| Accounts payables | -3.6 Million | -2.53 Million | 4.95 Million | 5.06 Million | 1.18 Million | -573 Thousand |
| Inventory | 3.41 Million | 1.05 Million | 1.79 Million | 14.16 Million | -8.09 Million | 6.86 Million |
| Other working capital | 7.13 Million | -8.96 Million | -11.17 Million | -1.09 Million | 30.11 Million | 21.92 Million |
| Cash at beginning of period | 228.61 Million | 238.94 Million | 259.57 Million | 176.23 Million | 284.79 Million | 272.02 Million |
| Cash at end of period | 172.89 Million | 228.61 Million | 239.99 Million | 239.99 Million | 259.57 Million | 284.79 Million |
| Capital Expenditure | -270 Thousand | -568 Thousand | -164 Thousand | -461 Thousand | -65 Thousand | -56 Thousand |
| Effect of forex changes on cash | - | - | -25.51 Million | - | 25.51 Million | - |
| Net cash flow / Change in cash | -55.71 Million | -10.33 Million | -19.58 Million | 63.75 Million | -25.21 Million | 12.76 Million |
| Free Cash Flow | 67.12 Million | 61.36 Million | 73.17 Million | 274.28 Million | 73.95 Million | 99.66 Million |
MICEL
EDXC
002778
CFFS
603722
CMFO